Product Images Olanzapine

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 13 images provide visual information about the product associated with Olanzapine NDC 65862-561 by Aurobindo Pharma Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 2.5 mg (30 Tablets Bottle) - olanzapine fig1

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 2.5 mg (30 Tablets Bottle) - olanzapine fig1

The text seems to be an information sheet for Aurobindo Pharma USA's Oinezine USP 2.5 mg tablets and Olanzapine Tablets USP. It includes details about dosage, storage, and dispensing information for pharmacists. The sheet also mentions the medication guide provided for patients and advises against use beyond the prescribed dosage.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 15 mg Blister Carton (10 x 10 Unit-dose) - olanzapine fig10

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 15 mg Blister Carton (10 x 10 Unit-dose) - olanzapine fig10

Olanzapine Tablets, USP are sold in a unit-dose package that is not child-resistant. Each tablet contains 15 mg of olanzapine USP. The normal dosage is available in the literature for complete dosing recommendations. The tablets should be stored at a controlled room temperature between 20°C to 25°C (68°F to 77°F) according to the USP guidelines. Patient medication guides should be given with the accompanying medication by the pharmacist. The manufacturer, Aurobindo Pharma USA, Inc., distributes 100 (10 X 10) unit-dose tablets of Olanzapine that are manufactured in India.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 20 mg (30 Tablets Bottle) - olanzapine fig11

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 20 mg (30 Tablets Bottle) - olanzapine fig11

Each tablet contains 20 mg of Olanzapine, distributed by Aurobindo Pharma USA Inc. with a usual recommended dosage indicated on the label. The medication guide must be enclosed in each tightly sealed container, stored between 20-25 degrees Celsius, and not to be used if the inner seal is broken.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 20 mg Blister Carton (10 x 10 Unit-dose) - olanzapine fig12

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 20 mg Blister Carton (10 x 10 Unit-dose) - olanzapine fig12

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 2.5 mg Blister Carton (10 x 10 Unit-dose) - olanzapine fig2

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 2.5 mg Blister Carton (10 x 10 Unit-dose) - olanzapine fig2

Olanzapine Tablets, USP is a medication guide containing tablets with 2.5 mg of Olanzapine USP. The usual dosage information is available in the literature. The tablets are stored at 20° to 25°C (68° to 77°F). It is available in a unit-dose package, AUROBINDO 100 (10 X 10) tablets. This medication guide is manufactured in India by Aurobindo Pharma USA, Inc. and has the code TS/DRUGS/22/2009. Additionally, Rx only warns that it's not child resistant. No other useful information is available as there are many errors.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 5 mg (30 Tablets Bottle) - olanzapine fig3

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 5 mg (30 Tablets Bottle) - olanzapine fig3

This is a description of a medication named Olanzapine Tablets, USP. Each tablet contains 5mg of the medication and is distributed by Aurobindo Pharma USA, Inc. The usual dosage information can be found on the label. It is important to keep the medication stored at 20°to 25° (68t 77 [See USP Cartrolled Foom. The pharmacist should dispense the medication guide that accompanies the 30 tablets to each patient.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 5 mg Blister Carton (10 x 10 Unit-dose) - olanzapine fig4

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 5 mg Blister Carton (10 x 10 Unit-dose) - olanzapine fig4

The text describes information about Olanzapine Tablet USP 5mg manufactured by Aurobindo Pharma USA, distributed in a unit-dose package. Each tablet contains Olanzapine USP 5mg. The usual dosage information is provided in the literature. The tablets should be stored at a temperature of 20°C to 25°C. Dispense the accompanying medication guide to each patient. The text also includes details about the product, its distribution, and its manufacturers.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 7.5 mg (30 Tablets Bottle) - olanzapine fig5

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 7.5 mg (30 Tablets Bottle) - olanzapine fig5

This text provides information about Aurobindo Pharma USA, Inc., and its distribution of Olanzapine Tablets, USP, including their usual dosage and storage guidelines. It also instructs pharmacists to dispense the accompanying medication guide to each patient and not to use the medication if the seal is broken.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 7.5 mg Blister Carton (10 x 10 Unit-dose) - olanzapine fig6

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 7.5 mg Blister Carton (10 x 10 Unit-dose) - olanzapine fig6

Olanzapine Tablets, USP is a medication used for the treatment of schizophrenia and bipolar disorder. Each tablet contains 7.5mg of Olanzapine USP. The complete dosage information is available in the literature. The tablets are stored at 20°C to 25°C. The unit-dose package is not child resistant. Aurobindo Pharma USA, Inc. located at 279 Princeton-Hightstown Road, East Windsor, NJ 08520 manufactures the medicine in India. Each patient must be provided with a medication guide.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 10 mg (30 Tablets Bottle) - olanzapine fig7

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 10 mg (30 Tablets Bottle) - olanzapine fig7

This is a description of a medication, Olanzapine Tablets, USP, produced by Aurobindo Pharma USA, Inc. Each bottle contains 30 tablets, with each tablet containing Olanzapine USP 10. The usual dosage information is listed in the enclosed literature. The pharmacist is instructed to dispense the accompanying medication guide to each patient and to ensure the medication is stored in a cool, dry place. The medication should be contained in an air-tight container, and the package should not be used if the inner seal is broken. The manufacturer's information is also provided on the package.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 10 mg Blister Carton (10 x 10 Unit-dose) - olanzapine fig8

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 10 mg Blister Carton (10 x 10 Unit-dose) - olanzapine fig8

This text is a label for a medication called Olanzapine Tablets, USP. It contains the name of the drug, dosage information, storage instructions and the manufacturer's details. The package is not child-resistant and a medication guide should be dispensed to each patient. The output also includes some unintelligible characters, which do not add any useful information to the description.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 15 mg (30 Tablets Bottle) - olanzapine fig9

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 15 mg (30 Tablets Bottle) - olanzapine fig9

This is a medication package for Olanzapine tablets distributed by Aurobindo Pharma USA, Inc. The package contains 30 tablets with a usual dosage mentioned in the enclosed leaflet. The medication guide should be given to each patient. It is advised to store the medication at room temperature in a tightly closed container. It also specifies not to use the medication if the inner seal is broken. The rest of the text is not readable.*

Chemical Structure - olanzapine str

Chemical Structure - olanzapine str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.